Myelomas
A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myeloma Patients (64007957MMY2010)
- Details
ClinicalTrials.gov ID:
NCT05972135
Diagnosis Type:
NA
USOR Number:
- Address
,
P: